Dr David Dodwell
BSc, MD, FRCP, FRCR
Senior Clinical Research Fellow
I am a senior breast oncologist based in Leeds with a number of research and governance activities. I am the lead oncologist on the Sloane, NHS screening & national HQIP breast cancer audits.
I am a senior clinical research fellow to the EBCTCG and a member of steering groups for 12 ongoing UK trials in breast cancer. I sit on the trial management committees for 3 trials.
I am UK lead for the SACT project (UK chemotherapy database) and chair the clinical group, which provides input and advice to this project to examine the safety, efficacy and cost-effectiveness of chemotherapy used in England.
Endocrine therapy in the years following a diagnosis of breast cancer: A proof of concept study using the primary care prescription database linked to cancer registration data.
Emanuel G. et al, (2019), Cancer Epidemiol, 61, 185 - 189
International Variation in Criteria for Internal Mammary Chain Radiotherapy.
Duane FK. et al, (2019), Clin Oncol (R Coll Radiol)
Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
Early Breast Cancer Trialists' Collaborative Group (EBCTCG) None., (2019), Lancet, 393, 1440 - 1452
Adjuvant treatment for breast cancer
Flatley MJ. and Dodwell DJ., (2019), Surgery (United Kingdom), 37, 176 - 180
The SMALL Trial: A Big Change for Small Breast Cancers
Morgan J. et al, (2019), Clinical Oncology